Associated Papers
A fatal case of VEXAS syndrome with a brief review.
Stoltman G et al.
Journal of Vascular Surgery Cases and Innovative Techniques, 2026
Genome Instability and Somatic Mutagenesis in Autoimmune Diseases.
Vijayraghavan S et al.
Cancers, 2026
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies.
Turturice BA et al.
Annals of the Rheumatic Diseases, 2026
Clinicopathological Challenge: Fixed Urticaria-Like Pink Papules in a Patient With Recurrent Fevers and Arthralgias.
Williams MCG et al.
International Journal of Dermatology, 2026
Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome.
Suárez EU et al.
Ejhaem, 2026
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.
Gavioli F et al.
Seminars in Arthritis and Rheumatism, 2026
Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review.
Hoff FW et al.
British Journal of Haematology, 2026
Periorbital oedema, trismus, myalgia as muscular manifestations of VEXAS syndrome: a case report and narrative literature review.
Archambeaud A et al.
Rheumatology (oxford, England), 2026
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.
Groarke EM et al.
Lancet (london, England), 2026
A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report.
Shahverdi E et al.
The American Journal of Case Reports, 2026
Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
Fiumara M et al.
Current Opinion in Rheumatology, 2026
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden.
Anderson M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2026
Independent mechanisms of inflammation and myeloid bias in VEXAS syndrome.
Narendra VK et al.
Nature, 2026
VEXAS syndrome presenting with features of Sjögren's disease: a case-based review of VEXAS and autoimmune disease overlap.
Groener M et al.
Clinical Rheumatology, 2026
A rare case of VEXAS syndrome.
Gupta K et al.
Rheumatology Advances in Practice, 2026
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management.
Elbadry MI et al.
Current Research in Translational Medicine, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.
Sakuma M et al.
Leukemia, 2025
Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.
Nowak D et al.
British Journal of Haematology, 2025
Monitoring Variant Allele Fraction in VEXAS Syndrome: A Comparison of Digital PCR and Next-Generation Sequencing.
Exposito-Bey A et al.
Ejhaem, 2025
UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice.
Dong G et al.
The Journal of Clinical Investigation, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter study.
Bourguiba R et al.
Journal of Internal Medicine, 2025
Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review.
Lin K et al.
Clinical Reviews in Allergy & Immunology, 2025
Interval Changes in Hematopoietic Vacuolization in VEXAS Syndrome with M41T Mutation: Insights into Diagnosis and Disease Progression.
Lee HW et al.
Clinical Laboratory, 2025
Developing efficient predictive models for the diagnosis of VEXAS syndrome.
Montes D et al.
Seminars in Arthritis and Rheumatism, 2025
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms.
Kaul A et al.
The Lancet. Rheumatology, 2025
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score.
von Bornemann Fløe L et al.
Journal of Clinical Immunology, 2025
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.
Ramakrishna C et al.
Practical Neurology, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome.
Rana G et al.
Rheumatology International, 2025
VEXAS syndrome caused by a UBA1 mutation is complicated by recurrent infections leading to hemophagocytic lymphohistiocytosis.
Tang Y et al.
Genes & Diseases, 2025